Analyst Research

Report Title Price
Provider: GlobalData
$250.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vascular Solutions, Inc. Reaffirms FY 2012 Guidance; Issues Q1 2012 Guidance; EPS Guidance Below Analysts' Estimates


Wednesday, 1 Feb 2012 04:15pm EST 

Vascular Solutions, Inc. announced that for fiscal 2012, it continues to target net revenue of between $94 million and $96 million. continues to project net earnings to be between $0.51 to $0.55 per fully diluted share. For the first quarter of 2012, it expects net revenue of between $22.3 million and $22.7 million, net income is projected to be between $0.10 and $0.11 per diluted share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $96 million and EPS of $0.54 fiscal 2012; revenues of $23.3 million and EPS of $0.12 for the first quarter of 2012. 

Company Quote

15.48
-0.31 -1.96%
11:23am EDT